Wei Lü
The University of Texas MD Anderson Cancer Center · 199 works · 2,759 citations · h-index 21
Top works
- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
- TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer
- Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
- An atlas of epithelial cell states and plasticity in lung adenocarcinoma
- Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration
- Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
- Challenges and Opportunities for Immunoprofiling Using a Spatial High-Plex Technology: The NanoString GeoMx® Digital Spatial Profiler
- Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
- Expression of TRPS1 in phyllodes tumor and sarcoma of the breast
- AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells
- Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
- Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
- Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway
- Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
- Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development
- 749 Impact of Bintrafusp alpha and radiotherapy in intrahepatic cholangiocarcinoma: proteomic and transcriptomic analysis
- RCRnorm: An integrated system of random-coefficient hierarchical regression models for normalizing NanoString nCounter data
- Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy
- KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib
- The immune landscape of undifferentiated pleomorphic sarcoma